Health · VanEck · NASDAQ
| Assets under management | $879.46M |
|---|---|
| Expense ratio | 0.36% |
| Category | Health |
| Dividend yield | 1.97% |
| NAV | $110.35 |
| Fund family | VanEck |
| Exchange | NASDAQ |
The largest positions VanEck Pharmaceutical ETF reports, by weight.
| Ticker | Fund | Assets | Expense |
|---|---|---|---|
| XLV | State Street Health Care Select Sector SPDR ETF | $40.60B | 0.08% |
| VHT | Vanguard Health Care Index Fund ETF Shares | $20.39B | 0.09% |
| XBI | State Street SPDR S&P Biotech ETF | $10.73B | 0.35% |
| IBB | iShares Biotechnology ETF | $9.09B | 0.44% |
| IXJ | iShares Global Healthcare ETF | $3.84B | 0.40% |
| FHLC | Fidelity MSCI Health Care Index ETF | $3.22B | 0.08% |
| IYH | iShares U.S. Healthcare ETF | $3.16B | 0.38% |
| IHI | iShares U.S. Medical Devices ETF | $3.02B | 0.38% |